'Given worsening funding pressures from higher demand and demographic changes, the NHS can ill afford to sacrifice resources for a higher drugs bill in the short term.' Eric Yang, Senior Economist at the Health Foundation
Following the US-UK drug pricing agreement, changes to the way the cost effectiveness of new medicines are assessed will drive up the NHS drugs bill.
In this new blog, Eric Yang argues that the higher bill means difficult decisions lie ahead for the government.
Read more ⬇️
https://bit.ly/3QrzvpX